Theralase Technologies Inc. TLT.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 22.75% | -40.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.75% | -40.31% | |||
| Cost of Revenue | 14.26% | 621.74% | |||
| Gross Profit | 31.77% | -69.78% | |||
| SG&A Expenses | 14.52% | -5.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.62% | 28.69% | |||
| Operating Income | -2.28% | -51.24% | |||
| Income Before Tax | -2.03% | -52.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.03% | -52.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.03% | -52.93% | |||
| EBIT | -2.28% | -51.24% | |||
| EBITDA | -3.23% | -57.12% | |||
| EPS Basic | 3.57% | -47.37% | |||
| Normalized Basic EPS | 5.56% | -50.00% | |||
| EPS Diluted | 3.57% | -47.37% | |||
| Normalized Diluted EPS | 5.56% | -50.00% | |||
| Average Basic Shares Outstanding | 7.08% | 1.75% | |||
| Average Diluted Shares Outstanding | 7.08% | 1.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||